Literature DB >> 23042076

Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell-derived neuroepithelial-like stem cells.

Donna McLaren1, Thorsten Gorba, Anita Marguerie de Rotrou, Gopalan Pillai, Clare Chappell, Alison Stacey, Sarah Lingard, Anna Falk, Austin Smith, Philipp Koch, Oliver Brüstle, Richard Vickers, Jon Tinsley, David Flanders, Paul Bello, Stewart Craig.   

Abstract

The aim of this study was to demonstrate proof-of-concept feasibility for the use of human neural stem cells (NSCs) for high-throughput screening (HTS) applications. For this study, an adherent human induced pluripotent stem (iPS) cell-derived long-term, self-renewing, neuroepithelial-like stem (lt-NES) cell line was selected as a representative NSC. Here, we describe the automated large-scale serum-free culture ("scale-up") of human lt-NES cells on the CompacT SelecT cell culture robotic platform, followed by their subsequent automated "scale-out" into a microwell plate format. We also report a medium-throughput screen of 1000 compounds to identify modulators of neural stem cell proliferation and/or survival. The screen was performed on two independent occasions using a cell viability assay with end-point reading resulting in the identification of 24 potential hit compounds, 5 of which were found to increase the proliferation and/or survival of human lt-NES on both occasions. Follow-up studies confirmed a dose-dependent effect of one of the hit compounds, which was a Cdk-2 modulator. This approach could be further developed as part of a strategy to screen compounds to either improve the procedures for the in vitro expansion of neural stem cells or to potentially modulate endogenous neural stem cell behavior in the diseased nervous system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042076     DOI: 10.1177/1087057112461446

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  15 in total

Review 1.  HTS/HCS to screen molecules able to maintain embryonic stem cell self-renewal or to induce differentiation: overview of protocols.

Authors:  Genesia Manganelli; Ugo Masullo; Stefania Filosa
Journal:  Stem Cell Rev Rep       Date:  2014-12       Impact factor: 5.739

2.  Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.

Authors:  Daozhan Yu; Manju Swaroop; Mengqiao Wang; Ulrich Baxa; Rongze Yang; Yiping Yan; Turhan Coksaygan; Louis DeTolla; Juan J Marugan; Christopher P Austin; John C McKew; Da-Wei Gong; Wei Zheng
Journal:  J Biomol Screen       Date:  2014-06-06

3.  Personalized medicine in a dish: the growing possibility of neuropsychiatric disease drug discovery tailored to patient genetic variants using stem cells.

Authors:  Kristen J Brennand
Journal:  Stem Cell Investig       Date:  2017-11-16

Review 4.  Phenotypic screens as a renewed approach for drug discovery.

Authors:  Wei Zheng; Natasha Thorne; John C McKew
Journal:  Drug Discov Today       Date:  2013-07-09       Impact factor: 7.851

Review 5.  Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models.

Authors:  Stephen J Haggarty; Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-07-19       Impact factor: 13.382

6.  Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency.

Authors:  Jignesh Tailor; Raja Kittappa; Ketty Leto; Monte Gates; Melodie Borel; Ole Paulsen; Sonia Spitzer; Ragnhildur Thora Karadottir; Ferdinando Rossi; Anna Falk; Austin Smith
Journal:  J Neurosci       Date:  2013-07-24       Impact factor: 6.167

Review 7.  Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish.

Authors:  Jasmine M McCammon; Hazel Sive
Journal:  Dis Model Mech       Date:  2015-07-01       Impact factor: 5.758

Review 8.  The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening.

Authors:  David M Gonzalez; Jill Gregory; Kristen J Brennand
Journal:  Front Cell Dev Biol       Date:  2017-12-19

9.  Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells.

Authors:  J C Neubauer; I Sébastien; A Germann; S C Müller; A Meyerhans; H von Briesen; H Zimmermann
Journal:  Cytotechnology       Date:  2016-11-28       Impact factor: 2.058

Review 10.  The role of microRNAs in human neural stem cells, neuronal differentiation and subtype specification.

Authors:  Laura Stappert; Beate Roese-Koerner; Oliver Brüstle
Journal:  Cell Tissue Res       Date:  2014-08-30       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.